COLUMBUS VENTURE PARTNERS
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate their commercialization.
COLUMBUS VENTURE PARTNERS
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Backswing Ventures
Backswing Ventures is a $50m venture fund investing in early stage companies in a broad range of industries.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-31 | Minoryx Therapeutics | Columbus Venture Partners investment in Series C - Minoryx Therapeutics | 51 M EUR |
| 2022-05-11 | Artax Biopharma | Columbus Venture Partners investment in Venture Round - Artax Biopharma | 26 M USD |
| 2022-03-29 | Integra Therapeutics | Columbus Venture Partners investment in Seed Round - Integra Therapeutics | 1.5 M EUR |
| 2021-07-07 | NeRRe Therapeutics | Columbus Venture Partners investment in Series B - NeRRe Therapeutics | 20 M GBP |
| 2021-03-22 | Aura Biosciences | Columbus Venture Partners investment in Venture Round - Aura Biosciences | 80 M USD |
| 2021-02-04 | Highlight Therapeutics | Columbus Venture Partners investment in Venture Round - Highlight Therapeutics | 22.6 M EUR |
| 2020-06-04 | Artax Biopharma | Columbus Venture Partners investment in Series B - Artax Biopharma | N/A |
| 2019-06-26 | SANIFIT | Columbus Venture Partners investment in Series D - SANIFIT | 55.2 M EUR |
| 2017-12-21 | Aura Biosciences | Columbus Venture Partners investment in Series C - Aura Biosciences | 30 M USD |
| 2017-05-04 | Vivet Therapeutics | Columbus Venture Partners investment in Series A - Vivet Therapeutics | 37.5 M EUR |